A double-blind clinical trial comparing World Health Organization oral rehydration solution with a reduced osmolarity solution containing equal amounts of sodium and glucose - 12/10/17
Abstract |
OBJECTIVE: To compare the safety and efficacy of an oral rehydration solution (ORS) containing 75 mmol/L of sodium and glucose each with the standard World Health Organization (WHO) ORS among Egyptian children with acute diarrhea. METHODS: One hundred ninety boys, ages 1 to 24 months, who were admitted to the hospital with acute diarrhea and signs of dehydration were randomly assigned to receive either standard ORS (311 mmol/L) or a reduced osmolarity ORS (245 mmol/L). Intake and output were measured every 3 hours. RESULTS: In the group treated with reduced osmolarity ORS, the mean stool output during the rehydration phase was 36% lower (95% confidence interval, 1%, 100%) than in those treated with WHO ORS. The relative risk of vomiting during the rehydration phase was significantly lower in children treated with reduced osmolarity ORS (relative risk, 2.4; 95% confidence interval, 1.2, 4.8). During the maintenance phase, stool output, mean intake of food and ORS, duration of diarrhea, and weight gain were similar in the treatment groups. The relative risk of treatment failure (need for unscheduled administration of intravenous fluids) was significantly increased in children receiving standard WHO ORS (relative risk, 7.9; 95% confidence interval, 1.1, 60.9). The mean serum sodium concentration at 24 hours was significantly lower in children receiving the reduced osmolarity ORS solution (134 ± 6 mEq/L) than in children receiving the standard WHO ORS (138 ± 7 mEq/L) (p <0.001). The relative risk of the development or worsening of hyponatremia was not increased in children given the reduced osmolarity ORS, and urine output was similar in the treatment groups. CONCLUSION: The reduced osmolarity ORS has beneficial effects on the clinical course of acute diarrhea in children by reducing stool output, and the proportion of children with vomiting during the rehydration phase, and by reducing the need for supplemental intravenous therapy. These results provide support for the use of a reduced osmolarity ORS in children with acute noncholera diarrhea. (J PEDIATR 1996;128:45-51)
Le texte complet de cet article est disponible en PDF.Abbreviations : CI, ORS, RR, WHO
Plan
 | From the Department of International Health, Center for American Indian and Alaskan Native Health, Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland, the Gastroenterology Unit, Hospital Abu El Reeche, Cairo University, Cairo, Egypt, the Combined Program in Pediatric GI and Nutrition, Harvard Medical School, Children's Hospital, Boston, Massachusetts, and the Diarrheal Disease Control Program, World Health Organization, Geneva, Switzerland |
| Supported by a grant from the Diarrheal Disease Control Program of the World Health Organization. |
 | Reprint requests: Mathuram Santosham, MD, MPH, Johns Hopkins University, 615 North Wolfe St., Room 5505, Baltimore, MD 21205. |
| 0022-3476/96/$5.00 + 0 9/20/68986 |
Vol 128 - N° 1
P. 45-51 - janvier 1996 Retour au numéro
Article précédent
- Variability in duration of stay in pediatric intensive care units: A multiinstitutional study
- Urs E. Ruttimann, Murray M. Pollack
- Frequent recurrence and persistence of varicella-zoster virus infections in children infected with human immunodeficiency virus type 1
- L. von Seidlein, S.G. Gillette, Y. Bryson, T. Frederick, L. Mascola, J. Church, P. Brunell, A. Kovacs, A. Deveikis, M. Keller, MD
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?